Lumen Technologies latest company sued over a PRT deal with Athene
As private equity firms continue hunting pension risk transfer deals, corresponding lawsuits from aggrieved pensioners are increasing as well.
A lawsuit filed last week in Colorado accused Lumen Technologies of bypassing its fiduciary obligations to select the “safest annuity available” in favor of a lucrative PRT deal with Athene Life & Annuity.
Athene, a wholly owned subsidiary of Apollo Global Management, is not named as a defendant in the lawsuit.
Plaintiffs Dolly Dow and Virginia Sakal are suing Lumen, State Street Global Advisors Trust and others over the $1.4 billion PRT deal completed in October 2021. The deal affected 22,600 Lumen retirees and their beneficiaries, the complaint says, which include Dow and Sakal.
Plaintiffs depended on their retirement benefits growing in a plan covered under the Employee Retirement Income Security. Act of 1974, the complaint reads.
“By offloading Lumen’s pension obligations to Athene, Defendants caused Plaintiffs and similarly situated Lumen retirees and their beneficiaries to lose their status as 'participants' in the Plan,” the complaint says. “Therefore, Plaintiffs are no longer entitled to ERISA’s protections for employee retirement benefits.”
Nothing in ERISA prohibits an employer from transferring pension obligations to an insurance company. PRT deals are booming business for firms looking for capital to invest in a higher interest rate environment.
'Entirely baseless attempt'
Through the first half of 2024, Athene had completed 48 pension risk deals worth $52.3 billion, according to its website. The deals cover more than 550,000 plan participants, Athene notes.
Athene is the leading seller of annuities in recent LIMRA sales rankings.
A spokesperson for Athene released this statement:
“This complaint is an entirely baseless attempt by class action attorneys to enrich themselves at the expense of retirees.
"Every pension group annuity participant whose benefits have been guaranteed by Athene has received and will receive their promised benefits in full. In each pension group annuity transaction for which Athene has been selected, there has been a robust review process carried out by a fiduciary and their independent advisers who are experts at assessing insurer safety.
"Athene operates from a position of outstanding financial strength and is a safe and secure provider of annuity benefits. We are properly reserved, and have excellent capitalization and strong credit ratings, with a recent rating upgrade to A+ by AM Best.”
PRT deals keep rising
Total PRT premium was $26 billion in the first half of 2024, 14% higher than prior year results, according to LIMRA’s U.S. Group Annuity Risk Transfer Sales Survey. While second-quarter numbers were down, the number of contracts sold increased 10% year over year.
“Broad plan sponsor interest continues,” said Keith Golembiewski, assistant vice president, director of LIMRA Annuity Research. “LIMRA is forecasting strong PRT sales in the second half of 2024.”
PRT lawsuits are on the rise as well. AT&T, Lockheed Martin, and Alcoa each were hit, during March and April of this year, with class-action lawsuits challenging the transfer of pension plan liabilities to Athene.
Those transactions ranged from $2 billion to $9 billion, with tens of thousands of plan participants, court documents say.
The law firm Schlichter Bogard handled all of those lawsuits and is representing Dow and Sakal as well.
“Athene structures its annuities to generate higher expected returns and profits for itself and its affiliates by investing in lower-quality, higher-risk assets rather than in quality assets that would better support its future benefit obligations,” the new complaint reads. “In transferring Plaintiffs’ pension benefits to Athene, Defendants put Lumen retirees’ and their beneficiaries’ future retirement benefits at substantial risk of default without appropriate compensation.”
A Sept. 3 lawsuit filed in the Southern District of New York makes similar allegations against Bristol-Myers Squibb and State Street Global over a $2 billion PRT deal. Former Bristol Myers employee Charles Doherty is represented by law firms Edward Stone Law and Zuckerman Spaeder in that lawsuit.
© Entire contents copyright 2024 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.
InsuranceNewsNet Senior Editor John Hilton has covered business and other beats in more than 20 years of daily journalism. John may be reached at [email protected]. Follow him on Twitter @INNJohnH.




Roof claims hitting a new high – and crisis – for insurance industry, experts say
ERISA’s enduring legacy and the evolving impact on fiduciaries
Advisor News
- Todd Buchanan named president of AmeriLife Wealth
- CFP Board reports record growth in professionals and exam candidates
- GRASSLEY: WORKING FAMILIES TAX CUTS LAW SUPPORTS IOWA'S FAMILIES, FARMERS AND MORE
- Retirement Reimagined: This generation says it’s no time to slow down
- The Conversation Gap: Clients tuning out on advisor health care discussions
More Advisor NewsAnnuity News
- Great-West Life & Annuity Insurance Company Trademark Application for “EMPOWER READY SELECT” Filed: Great-West Life & Annuity Insurance Company
- Retirees drive demand for pension-like income amid $4T savings gap
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
More Annuity NewsHealth/Employee Benefits News
- Uninterrupted coverage for thousands as Graves Gilbert, Humana announce new contract
- Unholy alliance of Democrats, insurers has ruined the system
- Trump releases health plan, but it’s short on specifics
- New Findings from University of Colorado in Managed Care and Specialty Pharmacy Provides New Insights (Primary Care Physicians Prescribe Fewer Expensive Combination Medications Than Dermatologists for Acne: a Retrospective Review): Drugs and Therapies – Managed Care and Specialty Pharmacy
- Reports Summarize Health and Medicine Research from UMass Chan Medical School (Supporting Primary Care for Medically and Socially Complex Patients in Medicaid Managed Care): Health and Medicine
More Health/Employee Benefits NewsLife Insurance News